Smith Sean Michael
SEC CIK 1914769 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NGNE | Neurogene Inc. | Principal Accounting Off | 21.6K | — | $4,448 | 6 | 2022-08-10 | 2023-08-11 |
Most active insiders at NGNE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cvijic Christine Mikail | Pres, CFO, Dir | — | $900.0K |
| 2 | Cobb Stuart | CSO | — | $141.4K |
| 3 | McMinn Rachel | CEO, Dir | — | $74.0K |
| 4 | Jordan Julie | Chief Medical Off | — | $18.1K |
Smith Sean Michael made no open-market trades at NGNE in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-14 | 2023-08-11 | NGNE | Neurogene Inc. | Smith Sean Michael | Interim CFO, Prin Acct Off | S - Sale+OE | $0.62 | -1,323 | 21.6K | -6% | -$820.26 |
| D | 2023-08-14 | 2023-08-10 | NGNE | Neurogene Inc. | Smith Sean Michael | Interim CFO, Prin Acct Off | M - OptEx | $0.00 | +5,000 | 23.0K | +28% | $0 |
| D | 2023-02-03 | 2023-02-01 | NGNE | Neurogene Inc. | Smith Sean Michael | Principal Accounting Off | M - OptEx | $0.00 | +12.5K | 19.3K | +184% | $0 |
| D | 2023-02-03 | 2023-02-02 | NGNE | Neurogene Inc. | Smith Sean Michael | Principal Accounting Off | S - Sale+OE | $0.6 | -3,316 | 16.0K | -17% | -$1,990 |
| D | 2022-08-12 | 2022-08-10 | NGNE | Neurogene Inc. | Smith Sean Michael | Principal Accounting Off | S - Sale+OE | $0.99 | -1,655 | 6,776 | -20% | -$1,638 |
| D | 2022-08-12 | 2022-08-10 | NGNE | Neurogene Inc. | Smith Sean Michael | Principal Accounting Off | M - OptEx | $0.00 | +5,000 | 8,431 | +146% | $0 |
Purchase Sale Sale after option exercise All abbreviations